Pathogenic roles of cardiac autoantibodies in dilated cardiomyopathy
- 31 July 2005
- journal article
- review article
- Published by Elsevier in Trends in Molecular Medicine
- Vol. 11 (7), 322-326
- https://doi.org/10.1016/j.molmed.2005.05.001
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Potential role of humoral immunity in cardiac dysfunction of patients suffering from dilated cardiomyopathyJournal of the American College of Cardiology, 2004
- Recent advances in therapeutic apheresisJournal of Artificial Organs, 2003
- The B7 Family of Ligands and Its Receptors: New Pathways for Costimulation and Inhibition of Immune ResponsesAnnual Review of Immunology, 2002
- Epidemiologic and Clinical Characteristics of Cardiomyopathies in Japan. Results From Nationwide Surveys.Circulation Journal, 2002
- Hemodynamic effects of immunoadsorption and subsequent immunoglobulin substitution in dilated cardiomyopathyJournal of the American College of Cardiology, 2000
- Peptides Derived from Cardiovascular G-protein-coupled Receptors Induce Morphological Cardiomyopathic Changes in Immunized RabbitsJournal of Molecular and Cellular Cardiology, 1997
- Removal of autoantibodies in dilated cardiomyopathy by immunoadsorptionInternational Journal of Cardiology, 1996
- Autoantibodies against Cardiac G-Protein-Coupled Receptors Define Different Populations with Cardiomyopathies but Not with HypertensionClinical Immunology and Immunopathology, 1994
- Heart-specific autoantibodies induced by Coxsackievirus B3: Identification of heart autoantigensClinical Immunology and Immunopathology, 1987
- An experimental model for congestive heart failure after encephalomyocarditis virus myocarditis in mice.Circulation, 1982